If you’re looking to start investing but don’t want to spend a lot of money, penny stocks are a great way to start.
But which stocks should be on your list, and are they safe?
In this article, we’ll be discussing the best stocks under $2 that you may add to your watchlist right now.
Best Stocks Under $2 To Buy Now (Updated List)
Pedevco (NYSE: PED)
Pedevco, short for Pacific Energy Development Company, is an energy firm headquartered in Houston, Texas. The company looks to acquire and develop oil and natural gas properties in areas where modern techniques have not yet been applied.
Its most significant assets are currently in New Mexico and Colorado, and the venture has made some exciting expansions over the past year. At the end of 2021, Pedevco brought two new horizontal oil wells online.
It has also taken steps to enhance its current assets for more efficient production by using more sustainable materials and processes. Pedevco’s most recent earnings reports have been very promising, with huge jumps in revenue, net income, and earnings per share.
In the three months ending April 23, 2025, the company averaged 1,074 boe/d still, but its stock now trades at $0.54—down from its 2022 highs—on a 52-week range of $0.47–$1.10
Bitfarms Ltd. (NASDAQ: BITF)
Bitfarms is a global cryptocurrency mining company that mines Bitcoin and other cryptocurrencies.
Founded in 2017, Bitfarms operates mining facilities in Canada, Israel, the United States, Paraguay, and Argentina.
Bitfarms makes money by mining cryptocurrency coins and tokens in North America, processing and verifying transactions on the blockchain, and earning Bitcoin as a reward.
Spot Bitcoin ETFs were approved by the SEC on January 10, 2024, and began trading January 11, 2024—making the ETF launch a historical event rather than a future catalyst. Bitcoin’s most recent halving took place on April 20, 2024, cutting the block reward to 3.125 BTC.
Being a low-cost miner, Bitfarms has been steadily growing its mining capacity.
As of April 23, 2025, Bitfarms closed at $1.00, up from sub-$1 levels earlier in April.
Denison Mines (NYSEAMERICAN: DNN)
Denison Mines is a Canadian mining and exploration venture with a specific focus on uranium. The company strives to be the first of its kind to provide uranium oxides at a low cost.
It has an effective 95% interest in the Wheeler River Uranium Project, the largest undeveloped area rich in uranium in northern Saskatchewan. Denison also has joint ventures with other businesses throughout Canada.
This diversity will help protect the mining enterprise should one mine shut down for any reason. Share prices have seen gains of 27% over the last year, kissing a share price of $1.75 at one point.
Also, the McClean Lake Tailings Management Facility’s expansion has received regulatory permission, according to the company’s announcement.
Additionally, it recently made a high-grade uranium mineral discovery at its 24.68% owned Waterfound River Joint Venture. With a solid year of mining ahead, Denison could uncover higher than ever stock numbers.
JD Sports Fashion ADR (OTCMKTS: JDSPY)
JD Sports Fashion plc is a retailer of branded kids’, women’s, and men’s sports fashion and outdoor apparel, accessories, footwear, and equipment. It runs in two segments: sports fashion and outdoor.
The company also distributes footwear, apparel, and sports apparel and accessories and retails leisure goods, sports goods, fishing gear, camping gear, boats, and bicycles.
Some of its popular sports brands include: JD, Size?, Footpatrol, Finish Line, Shoe palace, DTLR, Livestock, Sprinter, Sport Zone, Perry Sport and Sizeer.
The company’s latest second-quarter results showed an 8% uptick in its sizable revenues ($2.39 billion). Its net income also grew by 30% to nearly $120 million.
In the last five years, group revenue has grown by 106%, and headline PBT has grown by 179%, despite the Covid-19 impact.
Best Tech Stocks Under $2
Senseonics Holdings, Inc. (NYSE American: SENS)
Senseonics is a commercial-stage medical-technology firm that designs, develops, and manufactures long-term implantable continuous glucose monitors (CGMs), including its Eversense® E3 and year-long Eversense® 365 systems, targeting the diabetes management market.
The Eversense® 365 system received FDA clearance in September 2024 and began U.S. commercialization by year-end, adding recurring sensor-replacement revenue streams.
As of market close on April 24, 2025, SENS shares traded at $0.7580 (52-week range $0.25–$1.40), with a market cap near $482 M and a public float of ~604 M shares.
With its unique implantable-sensor niche, expanding reimbursement coverage, and low sub-$1 stock price, SENS is poised for re-rating as adoption of its year-long CGM accelerates.
Best Stocks Under 2 Dollars in Biotech Space
Atossa Therapeutics Inc (NASDAQ: ATOS)
Atossa Therapeutics Inc. (ATOS) is a clinical-stage biopharmaceutical company that develops innovative medicines for oncology. The company focuses on breast cancer and other breast conditions.
Atossa’s lead program is Endoxifen, an active metabolite of tamoxifen. Endoxifen is in Phase II clinical trials to treat and prevent breast cancer.
Atossa also offers treatment for Pre-cancerous breast conditions and Early-stage breast cancer
The company’s founder is Steven Quay, MD, PhD. It’s offices are based out of Seattle.
In the second quarter of 2023, each of the three ongoing Phase 2 trials investigating Atossa’s proprietary (Z)-endoxifen reached important milestones.
Moreover, it also received approval from Health Canada to conduct the Phase 2 EVANGELINE clinical trial in Canada. It had previously received approval from the FDA for the same trial.
As per the company’s financial release, EVANGELINE is a Phase 2 trial of (Z)-endoxifen and Exemestane + Goserelin as neoadjuvant treatment in premenopausal women with ER+/HER2- breast cancer.
While there are several FDA-approved neoadjuvant therapies for ER-breast cancers, few exist for ER+ patients, which account for approximately 78% of breast cancers.
The first dose was administered in April and positive findings in this trial would send the stock soaring.
The company reported cash equivalents of $99 million in its quarterly report, which should hold it in good stead while the trials go on.
ATOS is one of the few biopharmaceutical stocks that have grown positively in the current year and is trading below $2.
Zomedica Corp. (NYSE American: ZOM)
Zomedica is a veterinary-health company developing diagnostic and therapeutic platforms for companion animals. Its offerings include the PulseVet® shock-wave therapy system, the Triluminate® TRUFORMA® cytology platform, and the VetGuardian® monitoring device.
In 2023, ZOM grew revenue by 33% to $25 M and held $78 M in cash and equivalents as of Sept 30, 2024, underpinning its product rollout and international expansion.
As of April 23, 2025, ZOM closed at $0.0973, trading in a 30-day range of $0.0920–$0.127 with a market cap of $95.3 M.
With a strong liquidity position, accelerating adoption of its veterinary-point-of-care products, and sub-$0.10 share price, ZOM offers leveraged upside on near-term clinical and distribution milestones.
Should You Buy Stocks Under $2?
Buying stocks under $2 can be a good way for new investors to get into trading without the initial financial risk. While these stocks don’t cost much, there’s a genuine potential for them to double or triple in price in a relatively short period of time.
Investing in affordable penny stocks can have a big payoff if you’re strategic, as many of the world’s most exciting companies were once trading under $2 per share. However, there are some things to be aware of when purchasing these affordable stocks.
These penny stocks are known for seeing a lot of volatility on the market. A savvy investor can leverage this to make a nice return, although it’s unlikely that your penny stocks under $2 will eventually be worth thousands.
When buying stocks at these low prices, it is imperative to research the company ahead of time. You should have a good understanding of their business model and their recent performance before adding them to your portfolio.
Stocks under $2: Pros & Cons
Here are the top pros and cons of the best stocks under 2 USD:
Pros
Huge Growth Potential: Penny stocks are so appealing thanks to a massive growth potential. They can increase in value quickly and blow past averages from the overall market.
Low Entry Price: Stocks under $2 clearly sit at a low price point, meaning investors can scoop up shares for little money. Slight value increases can then lead to substantial gains.
Diversification: There’s a spot for stocks under $2 in most investment strategies to add some diversification to a portfolio. Having a spread of securities can help reduce risk and boost income over time.
Unique Opportunities: Many low-priced stocks are working to introduce innovations unlike anything we’ve ever seen in the market. Investing may allow you to become part of a world-changing trend before it takes off.
Short-Term Gains: While not for everyone, traders enjoy the up and down motion common to stocks under $2. If they play their cards right, it’s possible to get in at lows and sell high all in the same day.
Cons
Volatility: Although traders may see volatility differently, long-term investors favor a steady rise in share price over time. Stocks under $2 frequently succumb to market volatility that can erode investments fast.
Scams: Many so-called penny stocks are nothing more than pump and dump schemes set up by unscrupulous individuals. They artificially inflate the price of the stock and quickly sell at a profit, leaving everyone else with worthless shares.
Low Floats: Stocks under $2 may not have tons of shares circulating on the market. These low floats can become difficult to buy or sell even when opportunities arise. A huge share price increase isn’t worth anything if you’re not able to get rid of your stock.
Hard to Analyze: It’s not always easy to track the direction a stock under $2 is headed. Misleading information from less-regulated markets only add to the confusion. Unclear expectations of where a low-cost stock is heading can lead to disappointment.
Where to Buy Stocks Under $2
There are a limited number of sub $2 stocks on the major exchanges, as NASDAQ and the NYSE have specific requirements regarding the number of shares and trading volume to be listed.
If you want to peruse these markets, we suggest using Robinhood or Webull. Robinhood is best suited for newer traders with its low-key user interface. Webull speaks most to more experienced investors who want to dig a little deeper.
For OTC stocks, look to a trading app like Fidelity. Fidelity offers commission-free trading for even the lowest-valued tickers.
Final Thoughts
Stocks under $2 can be a great entry point for new traders. These tickers exist in every sector and in every exchange. It’s important to study potential picks before making an investment. No matter how sure a pick may seem, always keep an eye out for volatility.
FAQs
Below we’ve answered the top questions surrounding stocks under $2.
What Are the Best Stocks Under $2?
We’ve shared with you our favorite picks for this price range. Globalstar’s satellite reach is just starting to take shape as a major player in communication. Denison Mines is just starting to scrape the surface of uranium deposits it’s invested in.
What Is the Best $1 Stock To Buy?
With so many stocks to choose from, we’ve listed GEE Group as one of our top picks right now. The ticker is on the cutting edge of the job market and looks to grow in big ways. For more ideas, check out our best stocks under $1 guide.
What Is the Best $5 Stock?
Gran Tierra Energy Inc. (NYSE: GTE) has been on a tear recently. The company explores for, produces, and sells crude oil and natural gas in South America. It has a market cap of $471.63 million. In addition, the company posted a record net revenue of $48 million last year.
How Do I Find Penny Stocks?
Some penny stocks have enough volume to trade on NASDAQ or the NYSE. Still, others are found on over-the-counter markets that are more subject to volatility. No matter which way you go, a good penny stock trading platform will let you search for stocks that speak to you.
What Stocks Are Good for Beginners?
Penny stocks can be a great place for beginners to start investing in the stock market, as they offer the opportunity for high returns at a lower buy-in price.
Many penny stocks are not well known, so there is less competition among investors and greater potential for price appreciation.
Tags:
